Plain English Breakdown
The official text does not specify an effective date, so readers cannot know exactly when these rules begin.
Health Care Coverage for Colorectal Cancer Screening
This law updates rules so health plans must cover colorectal cancer screening tests approved by the FDA that meet federal requirements or are listed in American Cancer Society guidelines, without charging patients extra fees.
What This Bill Does
- Makes small, technical changes to existing laws about covering colorectal cancer screenings.
- Requires coverage for new screening tests if they are approved by the U.S. Food and Drug Administration AND either meet federal Centers for Medicare and Medicaid Services requirements or are included in recent American Cancer Society guidelines.
- Continues requiring zero cost sharing, meaning no copays or deductibles, for these screenings.
Who It Names or Affects
- Health care service plans regulated by the Department of Managed Health Care.
- Health insurers regulated by the Department of Insurance.
- People with health insurance policies issued, amended, or renewed on or after January 1, 2022.
Terms To Know
- Cost sharing
- Fees like copays or deductibles that patients pay when they use health care services.
- United States Preventive Services Task Force (USPSTF)
- A federal group that grades medical screening tests based on how well they work to prevent disease; existing law requires coverage for tests graded A or B by this group.
Limits and Unknowns
- The official text does not state a specific effective date.
- New requirements apply only if the test is FDA approved AND meets one of two additional conditions (CMS requirements or American Cancer Society guidelines).